Improving the Predictive Value of Prion Inactivation Validation Methods to Minimize the Risks of Iatrogenic Transmission With Medical Instruments

MLA

Mohammed Moudjou, et al. “Improving the Predictive Value of Prion Inactivation Validation Methods to Minimize the Risks of Iatrogenic Transmission With Medical Instruments.” Frontiers in Bioengineering and Biotechnology, vol. 8, Dec. 2020. EBSCOhost, https://doi.org/10.3389/fbioe.2020.591024.

APA

Mohammed Moudjou, Johan Castille, Bruno Passet, Laetitia Herzog, Fabienne Reine, Jean-Luc Vilotte, Human Rezaei, Vincent Béringue, & Angélique Igel-Egalon. (2020). Improving the Predictive Value of Prion Inactivation Validation Methods to Minimize the Risks of Iatrogenic Transmission With Medical Instruments. Frontiers in Bioengineering and Biotechnology, 8. https://doi.org/10.3389/fbioe.2020.591024

Chicago

Mohammed Moudjou, Johan Castille, Bruno Passet, Laetitia Herzog, Fabienne Reine, Jean-Luc Vilotte, Human Rezaei, Vincent Béringue, and Angélique Igel-Egalon. 2020. “Improving the Predictive Value of Prion Inactivation Validation Methods to Minimize the Risks of Iatrogenic Transmission With Medical Instruments.” Frontiers in Bioengineering and Biotechnology 8 (December). doi:10.3389/fbioe.2020.591024.